Drawing for QUICKCHECK

USPTO serial 98844692

QUICKCHECK

Status 730Notice of Allowance
Filing date
Nov 8, 2024
Status date
Jul 28, 2026
Registration date
Examiner
LEASER, ANDREW C

Need help with QUICKCHECK?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Owner

  • American Green Spring Diagnostics Inc

    POMONA, CA, US

  • American Green Spring Diagnostics Inc

    San Dimas, CA, US

Goods and services

ClassDescriptionStatusFirst use
005(Based on Use in Commerce) Ovulation test kits; Pregnancy test kits for home use; Reagents for use in diagnostic pregnancy tests for medical purposes; In-vitro ovulation prediction test kits for home use; (Based on Intent to Use) Drug testing kits comprised of medical diagnostic reagents and assays for detecting the presence of alcohol, marijuana, cocaine, amphetamine, methamphetamine, morphine 2000, barbiturates, benzodiazepines, methylenedioxy-methamphetamine, methadone, oxycodone, phencyclidine, buprenorphine, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), morphine, propoxyphene, tri-cyclic antidepressants and fentanyl in urine; Chemically treated papers for use in the detection of fecal occult blood; Reagents for blood grouping for medical or veterinary purposes; Reagents for blood typing for medical or veterinary purposes; Medical diagnostic test kits comprised of medical diagnostic reagents and assays for detecting the presence of infectious diseases, namely, COVID 19, HIV, HCV, H.Pylori and malariaACTIVEApr 1, 2023
010Clinical thermometers; Medical apparatus and instruments for monitoring vital signs, including blood pressure and heart rate, for use in home and clinical settings; Patient medical monitors for monitoring blood pressure, heart rate, and lung function, excluding use for peritoneal dialysis or peritonitis diagnosis; Nebulizers for medical purposes; Pulse oximeters for medical purposes; Pulse rate monitors; Spirometers; Thermometers for medical purposes; Electrotherapy devices for providing transcutaneous electrical nerve stimulation, infrared heat, and compression; Embedded software for communicating temperature data to track illness symptoms sold as a component of thermometers for medical purposes; Infrared thermometers for medical purposesACTIVE

Prosecution history

DateCodeEvent
Jul 28, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2026EX1GSOU EXTENSION 1 GRANTED
Jul 27, 2026EXT1SOU EXTENSION 1 FILED
Jul 27, 2026EEXTSOU TEAS EXTENSION RECEIVED
Jul 27, 2026EPPATEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 27, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 16, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 14, 2025CHPBPOST PUBLICATION AMENDMENT - ENTERED
Dec 11, 2025APETASSIGNED TO PETITION STAFF
Oct 23, 2025EPPATEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 24, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Aug 26, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025PUBOPUBLISHED FOR OPPOSITION
Aug 20, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 9, 2025GNRTNON-FINAL ACTION E-MAILED
Jul 9, 2025CNRTNON-FINAL ACTION WRITTEN
Jun 13, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2025GNRTNON-FINAL ACTION E-MAILED
May 14, 2025CNRTNON-FINAL ACTION WRITTEN
May 7, 2025DOCKASSIGNED TO EXAMINER
Apr 26, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2024NWAPNEW APPLICATION ENTERED

Related guidance